Reuters logo
BRIEF-Alembic Pharma gets USFDA nod for itraconazole capsules
December 16, 2016 / 5:08 AM / a year ago

BRIEF-Alembic Pharma gets USFDA nod for itraconazole capsules

Dec 16 (Reuters) - Alembic Pharmaceuticals Ltd

* Alembic Pharmaceuticals receives USFDA approval for itraconazole capsules

* Itraconazole capsules are indicated for the treatment of blastomycosis, histoplasmosis and aspergillosis

* Source text: bit.ly/2hAnBIy Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below